THE Pan American Health Organization (PAHO) has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to analyse the manufacturing potential of the region of the Americas, under the recently launched Regional Platform Initiative.
This, with a view to reducing the region’s reliance on pharmaceutical imports by strengthening PAHO’s role at every stage of the supply chain, particularly in relation to vaccines for viral diseases like the COVID-19, Director General Dr Carissa Etienne has said.
CEPI is a global partnership, launched in 2017, to finance and coordinate the development of new vaccines to prevent and contain infectious disease epidemics.
Speaking during PAHO’s weekly COVID-19 digital media briefing on Wednesday, Dr Etienne also advised that the organisation is working directly with the entities already selected to participate in the regional platform initiative to strengthen their capacity to develop and produce COVID mRNA vaccines, among others.
To read the full article by The Jamaica Observer, please click here.